Partners & Investors
Opimend is actively interested in strategic partnerships with non-profit organizations, companies, researchers and investors that complement Opimend’s development plans.
Investigators and institutions interested in conducting investigator-initiated pre-clinical and clinical trials with our proprietary formulations.
Early asset licensing at individual country or regional level.
Co-development agreements with pharma/biotech companies interested in solutions for the opioid crisis.
Non-profit organizations, private and institutional investors interested in investing in our promising technologies.